These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Ocular quinine toxicity followed by electroretinogram, electro-oculogram, and pattern visually evoked potential. Zahn JR; Brinton GF; Norton E Am J Optom Physiol Opt; 1981 Jun; 58(6):492-8. PubMed ID: 7270659 [TBL] [Abstract][Full Text] [Related]
10. An experimental treatment of ocular quinine toxicity with high-dose 9-cis Beta-carotene. Meshi A; Belkin A; Koval T; Kornhouser T; Assia EI; Rotenstreich Y Retin Cases Brief Rep; 2015; 9(2):157-61. PubMed ID: 25545373 [TBL] [Abstract][Full Text] [Related]
11. Morphologic and functional retinal changes in myotonic dystrophy unrelated to quinine therapy. Mausolf FA; Burns CA; Burian HM Am J Ophthalmol; 1972 Dec; 74(6):1141-3. PubMed ID: 4646720 [No Abstract] [Full Text] [Related]
12. Toxic maculopathy. Part I. A result of quinine usage. Maltzman B; Sutula F; Cinotti AA Ann Ophthalmol; 1975 Oct; 7(10):1321-6. PubMed ID: 1190657 [TBL] [Abstract][Full Text] [Related]
13. [Harmful effects of common drugs on the visual apparatus. Quinine]. Watillon M Bull Soc Belge Ophtalmol; 1972; 160(1):426-30. PubMed ID: 5047223 [No Abstract] [Full Text] [Related]
17. [Persistence of peripheral temporal visual field after quinine intoxication]. Rossazza C; Rogez JP Bull Soc Ophtalmol Fr; 1970; 70(7):838-44. PubMed ID: 5526311 [No Abstract] [Full Text] [Related]
18. Toxic maculopathy part II: A result of quinine usage as demonstrated by fluorescein angiography and electroretinography. Pruzon H; Kiebel G; Maltzman B Ann Ophthalmol; 1975 Nov; 7(11):1475-81. PubMed ID: 1200559 [TBL] [Abstract][Full Text] [Related]